sterna biologicals GmbH & Co KG

Industry / private company


Location: Marburg, Germany (DE) DE

ISNI: -

ROR: https://ror.org/05nx4j589

Show on Map:

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Targeting the transcription factor GATA3 by the DNAzyme formulation SB012 in patients with moderately-to-severely active ulcerative colitis: a multicenter, randomized, placebo-controlled, phase 2a induction trial (2026) Atreya R, Kühbacher T, Vieth M, Jefremow A, Hirschmann S, Waldner M, Fischer S, et al. Journal article Luminal application of a GATA3-specific DNAzyme ameliorates mucosal inflammation in a randomised trial with active ulcerative colitis patients (2018) Atreya R, Kuehbacher T, Schmitt H, Hirschmann S, Waldner M, Drvarov O, Fischer SM, et al. Conference contribution Rectal Delivery of a DNAzyme That Specifically Blocks the Transcription Factor GATA3 and Reduces Colitis in Mice (2017) Popp V, Gerlach K, Mott S, Turowska A, Garn H, Atreya R, Lehr HA, et al. Journal article